Do Heart Disease And Cancer Have A Common Genetic Link?

November 03, 1997

New York, NY (November 3, 1997) -- Heart disease and cancer, the two leading causes of death in the US, may have a common genetic cause, according to researchers at Cornell University Medical College. Their findings are published in the November 1 issue of the Journal of Clinical Investigation.

Lead author Dr. Timothy McCaffrey and his colleagues suggest that atherosclerosis, like some forms of cancer, may be linked to a mutation in a single cell that could spread and cause disease. Atherosclerosis, or blockage of the coronary arteries, is the most common cause of heart disease.

"We have suspected for decades that cancer and heart disease have similar underlying causes, particularly their tendency to derive from the abnormal growth of a single cell," said Dr. McCaffrey. "Our finding is a precise molecular defect that may be one marker for this process and may also suggest mechanisms by which this process may occur."

In atherosclerosis, smooth muscle tissue cells migrate to the inner layer of the blood vessel, and proliferate and multiply. This uncontrolled growth causes blockage of the blood vessel. It is also known that the growth factor protein TGF-beta is a potent inhibitor of cell growth; however, atherosclerotic tissue is resistant to TGF-beta's beneficial effects

Therefore, McCaffrey and his colleagues decided to look for defects in the gene that encodes one of the cellular receptors of TGF-beta, the Type II TGF-beta receptor or RII gene. Their reasoning was based on previous studies by other investigators that showed that the RII gene is also altered in colon cancer tumors, specifically in the area of the gene containing a stretch of ten adenosine bases (adenosine is one of the four bases that make up DNA). This adenosine-rich region is prone to errors, also called mutations, during the replication of the DNA. And these mutations cause resistance to the effects of TGF-beta which can lead to cancer.

Dr. McCaffrey and his colleagues discovered mutations in the same area of the gene in atherosclerotic tissue, which suggests that the same mechanism underlies both diseases, in some patients.

"Dr. McCaffrey's research gives us a new understanding of two of the most common diseases associated with aging -- cancer and atherosclerosis. The fact that a similar mechanism (i.e., a mutation in the DNA of a single cell) could play a part in diseases as diverse as cancer and atherosclerosis suggests that other diseases of aging might also be traced back to a similar single-cell mutation," said Dr. David Finkelstein, PhD, of the National Institute on Aging.

"We believe that these results are important because it gives us new avenues toward understanding the progression of cardiovascular disease," said Dr. McCaffrey. "The TGF-beta receptor is one pathway that normally suppresses cell proliferation, and its inactivation leads to slow, but uncontrolled, growth in the artery."

"However," he added, "We know that there are other systems that also can suppress growth, and so it will be very interesting to see if those systems are affected in patients. By determining the most common pathways that are affected, we can design diagnostic and therapeutic strategies that target those systems, or optimize treatments that circumvent these defective pathways."

This study reflects the close collaboration of basic scientists with cardiologists and vascular surgeons, including Dr. Timothy Sanborn and Dr. Harry Bush, both of The New York Hospital-Cornell Medical Center. Dr. McCaffrey's research was supported by the National Heart, Lung, and Blood Institute and the National Institute on Aging.

# # # #

NIH/National Institute on Aging

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to